Patents by Inventor Friedrich Grimminger

Friedrich Grimminger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use for PDE5 inhibitors
    Patent number: 8278300
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Grant
    Filed: January 4, 2010
    Date of Patent: October 2, 2012
    Assignee: Nycomed GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
    Publication number: 20120196867
    Abstract: The claimed subject matter relates to pharmaceutical compositions comprising a PDE4 inhibitor and a PDE5 inhibitor and the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: April 12, 2012
    Publication date: August 2, 2012
    Applicant: NYCOMED GMBH
    Inventors: Torsten DUNKERN, Armin HATZELMANN, Christian SCHUDT, Friedrich GRIMMINGER, Hossein Ardeschir GHOFRANI
  • COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
    Publication number: 20100234382
    Abstract: The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 16, 2010
    Applicant: NYCOMED GMBH
    Inventors: Torsten DUNKERN, Armin HATZELMANN, Christian SCHUDT, Friedrich GRIMMINGER, Hossein Ardeschir GHOFRANI
  • Novel use for PDE5 inhibitors
    Publication number: 20100179152
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: January 4, 2010
    Publication date: July 15, 2010
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Use for PDE5 inhibitors
    Patent number: 7666872
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: February 23, 2010
    Assignee: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Use of Pde1c and Inhibitors Thereof
    Publication number: 20090030065
    Abstract: The present invention relates to the use of PDE1C as a novel target for the identification of compounds, which can be used for the treatment of pulmonary hypertension, fibrotic lung diseases or other fibrotic diseases outside the lung. The present invention further relates to the use of PDE1C inhibitors in the manufacture of pharmaceutical compositions for use in the therapy of those diseases.
    Type: Application
    Filed: June 13, 2006
    Publication date: January 29, 2009
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Armin Hatzelmann, Friedrich Grimminger, Ralph Schermuly
  • Novel use for pde5 inhibitors
    Publication number: 20070185114
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: March 3, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
    Publication number: 20050181066
    Abstract: The invention relates to the novel use of guanylate cyclase activators for the treatment of partial and global respiratory failure.
    Type: Application
    Filed: April 24, 2003
    Publication date: August 18, 2005
    Applicant: Altana Pharma AG
    Inventors: Friedrich Grimminger, Ralph Schermuly, Christian Schudt
  • Novel use of selective pde5 inhibitors
    Publication number: 20050107394
    Abstract: The invention relates to the novel use of PDE5 inhibitors for the treatment of patients in which a mismatch is present.
    Type: Application
    Filed: December 14, 2002
    Publication date: May 19, 2005
    Inventors: Ardeschir Ghofrani, Friedrich Grimminger, Christian Schudt
  • Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases
    Patent number: 5589508
    Abstract: An emulsion containing one or several polyunsaturated, long-chain omega-3 and/or omega-6 fatty acids or their pharmaceutically tolerable esters or salts, as well as usual adjuvants and additives, is used to produce an intravenously administered medicament for treating skin diseases, in particular inflammatory skin diseases, as well as diseases of the dermatitis or eczema group. Preferably, fatty acids containing 18-22 carbon atoms, as well as their pharmaceutically tolerable esters of salts, are used. These acids or their pharmaceutically tolerable esters or salts may be used in their pure form or as components of oils, such as fish oil, highly-purified fish oil concentrates, linseed oil, primrose oil, borage oil or soya oil. Specially preferred are the pharmaceutically tolerable esters or salts of said acids, in particular the pharmaceutically tolerable esters, especially those derived from eicosapentaenic acid.
    Type: Grant
    Filed: April 20, 1994
    Date of Patent: December 31, 1996
    Assignee: Fresenius AG
    Inventors: Ewald Schlotzer, Peter Mayser, Friedrich Grimminger, Werner Seeger, Burghard Weidler, Klaus Sommermeyer, Martin Thomas